Advertisement
Screener

VERTEX PHARMACEUTICALS INC / MA (VRTX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

VERTEX PHARMACEUTICALS INC / MA Cash Flow Breakdown

Cash flow breakdown shows where VERTEX PHARMACEUTICALS INC / MA's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $3.63B came in.
  • Fiscal year ended 2025-12-31: from investing, $945.40M went out.
  • Fiscal year ended 2025-12-31: from financing, $2.26B went out.
  • Fiscal year ended 2025-12-31: change in cash, $515.60M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31$3.63B-$945.40M-$2.02B-$369.90M$55.60M$3.70M$66.70M*$515.60M
2024-12-31-$492.60M-$3.77B-$1.18B-$405.00M$50.00M$6.20M$31.00M*-$5.80B
2023-12-31$3.54B-$3.14B-$427.60M-$226.10M$80.80M$1.80M$8.90M*-$139.70M
2022-12-31$4.13B-$321.10M$0.00-$172.00M$144.60M$3.50M-$43.80M*$3.71B
2021-12-31$2.64B-$340.90M-$1.43B-$135.90M$64.20M$5.70M$13.40M*$811.20M
2020-12-31$3.25B$99.40M-$539.10M-$200.30M$228.20M-$1.80M$7.70M*$2.87B
2019-12-31$1.57B-$1.24B-$186.00M$0.00-$6.00M$317.80M$4.80M-$3.80M*$462.40M
2018-12-31$1.27B-$202.16M-$350.04M$0.00$0.00$263.40M$2.08M$13.35M*$990.73M
2017-12-31$844.94M-$483.33M$0.00-$300.00M$323.30M$0.00$45.10M*$435.82M
2016-12-31$236.10M$51.24M$0.00$0.00$48.50M$0.00*$84.77M*$415.95M
2015-12-31-$365.43M$268.86M$0.00$0.00$165.60M$0.00$23.32M*$89.51M
2014-12-31-$573.11M$82.01M$2.16M$547.08M*
2013-12-31-$60.67M-$112.56M-$158.00K-$1.25M$249.82M*
2012-12-31$267.84M-$425.82M$0.00$0.00-$16.90M*$189.11M*
2011-12-31$143.74M$212.41M-$155.00M$0.00$900.00K*$29.86M*
2010-12-31-$635.44M$7.30M$0.00$391.64M$0.00*$33.41M*-$203.46M
2009-12-31-$427.59M-$508.73M$801.38M$197.62M*$57.54M
2008-12-31-$226.48M-$360.65M-$20.00M$278.61M$330.14M$31.98M*$33.45M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$1.13B*-$45.80M*-$469.50M*-$4.30M*-$600.00K*$47.70M*
2026-03-31$1.43B-$431.90M-$336.90M-$228.50M-$400.00K$27.00M*$417.10M
2025-12-31$498.00M*-$288.10M*-$128.40M*-$2.50M*$1.10M*$52.60M*
2025-09-30$1.24B*-$117.00M*-$1.07B*-$91.00M*$3.70M*$3.90M*
2025-06-30$1.07B*-$484.50M*-$391.80M*-$5.90M*-$600.00K*$49.10M*
2025-03-31$818.90M-$55.80M-$426.10M-$270.50M-$500.00K$16.70M*$113.20M
2024-12-31$584.60M*-$821.90M*-$417.90M*-$7.30M*$900.00K*$33.00M*
2024-09-30$1.37B*-$348.00M*-$307.70M*-$83.70M*$900.00K*$3.00M*
2024-06-30-$3.75B*-$463.70M*-$320.30M*-$80.50M*$900.00K*$41.30M*
2024-03-31$1.31B-$2.14B-$131.20M-$233.50M$3.50M$3.70M*-$1.20B
2023-12-31$234.60M*-$886.50M*-$149.50M*-$3.20M*-$1.50M*$34.40M*
2023-09-30$1.27B*-$117.70M*-$117.00M*-$53.20M*$1.10M*$4.10M*
2023-06-30$1.13B*-$303.90M*-$28.30M*-$3.10M*$1.10M*$47.60M*
2023-03-31$899.90M-$1.83B-$132.80M-$166.60M$1.10M$3.60M*-$1.22B
2022-12-31$1.08B*$175.60M*$0.00*-$2.10M*$1.10M*$41.20M*
2022-09-30$955.50M*-$384.20M*$0.00*-$48.00M*$700.00K*-$12.90M*
2022-06-30$1.14B*-$61.50M*$0.00*-$4.40M*$400.00K*$51.70M*
2022-03-31$956.20M-$51.00M$0.00-$117.50M$1.30M$20.80M*$803.90M
2021-12-31$995.00M*-$134.00M*-$368.20M*-$1.70M*$1.40M*$32.30M*
2021-09-30$927.20M*-$52.90M*-$632.30M*-$28.50M*$1.40M*$2.70M*
2021-06-30-$199.70M*-$79.70M*$0.00*-$3.60M*$1.60M*$35.60M*
2021-03-31$921.00M-$74.30M-$424.90M-$102.10M$1.30M$7.00M*$324.00M
2020-12-31$491.53M*$243.76M*-$131.07M*-$20.52M*$2.60M*$23.78M*
2020-09-30$907.75M*-$247.94M*-$108.01M*-$40.53M*-$6.11M*$13.96M*
2020-06-30$1.04B*$71.91M*$0.00*-$3.08M*$87.00K*$123.02M*
2020-03-31$815.70M$31.67M-$300.03M-$136.17M$1.62M$75.14M*$481.28M
2019-12-31$445.98M*-$896.97M*-$35.98M*-$64.00K*$5.93M*$191.56M*
2019-09-30$334.79M*-$249.00M*$0.00*-$104.00K*-$1.13M*$21.59M*
2019-06-30$463.75M*-$50.19M*-$56.01M*$0.00*$0.00*$42.99M*
2019-03-31$324.78M-$39.14M-$94.01M-$5.83M$0.00$57.85M*$243.28M
2018-12-31$314.58M*-$40.90M*-$143.00M*$0.00*$3.08M*$38.88M*
2018-09-30$381.35M*-$49.89M*-$92.00M*$0.00*-$851.00K*$94.94M*
2018-06-30$321.70M*-$116.30M*-$105.03M*$0.00*$851.00K*$52.97M*
2018-03-31$252.66M$4.93M-$10.00M$0.00-$1.00M$89.96M*$338.20M
2017-12-31$227.51M*-$20.79M*$0.00*$0.00*$0.00*$73.23M*$280.45M*
2017-09-30$170.09M*-$225.28M*$0.00*$0.00*$238.00K*$152.47M*$161.84M*
2017-06-30$181.65M*-$76.28M*$0.00*$0.00*-$121.00K*$132.15M*$219.45M*
2017-03-31$265.69M-$160.98M$0.00-$300.00M-$117.00K$10.55M*-$183.46M
2016-12-31$144.72M*$176.94M*$0.00*$93.76M*$464.25M*
2016-09-30$65.66M*$34.79M*$0.00*$13.55M*$113.83M*
2016-06-30$40.86M*-$57.78M*$0.00*$21.25M*$1.62M*
2016-03-31-$15.14M-$102.71M$0.00$4.70M*-$110.52M
2015-12-31$29.14M*-$122.69M*$52.64M*-$41.48M*
2015-09-30-$62.07M*-$100.94M*$0.00*$49.67M*-$114.29M*
2015-06-30-$110.27M*$278.44M*$0.00*$36.20M*$205.66M*
2015-03-31-$222.24M$214.04M$0.00$50.41M*$39.62M
2014-12-31-$181.78M*-$18.01M*-$68.30M*$176.48M*
2014-09-30-$87.65M*$30.55M*$0.00*$0.00*$357.23M*
2014-06-30-$127.92M*$89.88M*$0.00*$33.41M*
2014-03-31-$175.76M-$20.41M$8.05M$42.37M*
2013-12-31$19.76M*-$119.81M*-$5.54M*$89.59M*
2013-09-30-$13.72M*$49.54M*$0.00*-$19.13M*$32.13M*
2013-06-30-$927.00K*-$4.69M*-$26.41M*$183.89M*
2013-03-31-$65.78M-$37.60M-$17.71M*$11.57M*
2012-12-31$40.56M*$7.16M*-$11.73M*$16.56M*
2012-09-30$105.96M*-$131.23M*-$6.39M*$14.54M*
2012-06-30$118.41M*-$70.04M*$987.00K*$136.71M*
2012-03-31$2.92M-$231.70M$227.00K*$21.30M*
2011-12-31$503.66M*-$387.78M*-$105.00M*-$77.98M*
2011-09-30$42.90M*$21.45M*$0.00*$20.07M*
2011-06-30-$216.19M*$172.79M*$0.00*$55.03M*$11.66M*
2011-03-31-$186.63M$405.95M-$50.00M$33.64M*$203.34M
2010-12-31-$166.10M*-$169.69M*$0.00*$9.45M*-$326.70M*
2010-09-30-$163.99M*-$2.41M*$398.50M*$232.29M*
2010-06-30-$108.89M*$40.65M*$9.47M*-$58.94M*
2010-03-31-$196.46M$138.76M$7.64M*-$50.11M
2009-12-31-$102.33M*-$547.78M*$488.13M*$50.53M*-$112.47M*
2009-09-30-$21.64M*$42.52M*$0.00*$130.59M*$150.18M*
2009-06-30-$118.06M*-$83.66M*$0.00*$11.08M*-$193.25M*
2009-03-31-$185.56M$80.18M$313.25M$5.42M*$213.08M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64